Gliclazide Glizid M is a sulfonylurea hypoglycemic agent which reduces blood glucose levels in type 2 diabetes mellitus by increasing the release of insulin from pancreatic cells It primarily enhances the 1st phase of insulin secretion but also to a degree its 2nd phase Both phases are diminished in type 2 diabetes mellitus

Some diabetic patient taking Glizid M Tablet 15 s may develop a rare but serious condition called lactic acidosis In this condition there is too much of lactic acid accumulated in the blood So your liver and kidney proper functioning is required for elimination of excess lactic acid from the blood You should not take Glizid M Tablet 15 s if you have kidney disease as measured by a blood test Glizid M Tablet 15 s may lower vitamin B12 levels so try to have blood test annual blood and vitamin Glizid M Tablet 15 s when used with or without insulin has the tendency to extremely lower the blood sugar level So the doctor may lower the dose of insulin Glizid M Tablet 15 s may lower your thyroid stimulating hormone TSH so annual check up of TSH is suggested